Banner
Social Media Is A Faster Source For Unemployment Data Than Government

Government unemployment data today are what Nielsen TV ratings were decades ago - a flawed metric...

Gestational Diabetes Up 36% In The Last Decade - But Black Women Are Healthiest

Gestational diabetes, a form of glucose intolerance during pregnancy, occurs primarily in women...

Object-Based Processing: Numbers Confuse How We Perceive Spaces

Researchers recently studied the relationship between numerical information in our vision, and...

Males Are Genetically Wired To Beg Females For Food

Bees have the reputation of being incredibly organized and spending their days making sure our...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Today's young millennial voters are seen as a key demographic for political victory in many races this fall. Now, new research suggests that millennials' political views differ significantly from young people from previous generations.

A team led by San Diego State University psychology professor Jean Twenge, author of the book "Generation Me," examined data from three large, nationally representative surveys of high school seniors, entering college students and adults in the United States administered since the 1970s. The surveys included responses to a variety of political questions from 10 million participants.

The Grolier Codex, an ancient document that is among the rarest books in the world, has been regarded with skepticism since it was reportedly unearthed by looters from a cave in Chiapas, Mexico, in the 1960s, but a new study claims it is both genuine and likely the most ancient of all surviving manuscripts from ancient America.

For years, academics and specialists have argued about the legitimacy of the Grolier Codex, a legacy the authors trace in the paper. Some asserted that it must have been a forgery, speculating that modern forgers had enough knowledge of Maya writing and materials to create a fake codex at the time the Grolier came to light.

Users of both electronic nicotine delivery systems (ENDS) and cigarettes may be more intent on quitting tobacco, but that intention seems to drop off among less educated smokers, according to a study by Georgia State University researchers published in the journal Addictive Behaviors.

Through a survey of more than 1,200 smokers, researchers found those who did not have college degrees were less likely to use ENDS in addition to smoking regular cigarettes. But smokers who did use ENDS, such as e-cigarettes, were more likely to have attempted to quit in the past year, according to the survey data.

ALEXANDRIA, Va. - A team of researchers, using a novel approach, found that while many cancer centers offer palliative and supportive care services, patients may face challenges when trying to access them. The study showed that expanding awareness and education to patient-facing cancer center employees about such services could make an important difference. This study will be presented at the upcoming 2016 Palliative Care in Oncology Symposium in San Francisco.

A new Tel Aviv University study on women in the workplace finds women are as savvy and exacting as their male counterparts when negotiating with or on behalf of friends.

The study was conducted by Dr. Hilla Dotan of TAU's Coller School of Management and Prof. Uta Herbst of Potsdam University in Germany. It will appear in an upcoming issue of the Journal of Business and Industrial Marketing.

Dr. Dotan and her team conducted two laboratory studies, which paired 216 MBA students in single-gender teams, some of whom were friends and some of whom were not. The teams engaged in several multi-issue negotiations -- concerning pesticide products in one scenario, and airplane engines and parts in another.

Eribulin (trade name: Halaven) has been approved since May 2016 for the treatment of adults with advanced liposarcoma. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in these patients.

According to the findings, the dossier contained no data suitable for the assessment: In the only study of direct comparison, the dosage of the drug in the comparator arm was not in compliance with the approval. It was not ensured in an indirect comparison that the respective patient populations were sufficiently similar. An added benefit of eribulin is therefore not proven.

New therapeutic indication of eribulin